|
MK-8591-016 |
PrEP |
II |
September 2019 |
United States of America, Malawi, South Africa, Israel |
Men |
Islatravir (MK-8591) |
Ongoing |
|
CONRAD B17-144 |
Microbicides, Multipurpose Prevention Technologies |
II |
December 2018 |
Kenya |
Women |
TFV/LNG ring, TFV ring |
Ongoing |
|
CONRAD A15-140 |
Microbicides, PrEP |
I |
April 2016 |
United States of America |
Women |
TFV ring, TDF/FTC (Truvada) |
Completed |
|
CONRAD A15-138 |
Microbicides, Multipurpose Prevention Technologies |
I |
September 2017 |
United States of America, Dominican Republic |
Men |
Levonorgestrel, tenofovir |
Completed |
|
Population Council #728 |
Microbicides |
I |
October 2017 |
United States of America |
Women |
PC-6500 |
Completed |
|
Population Council #558 |
Microbicides, Multipurpose Prevention Technologies |
I |
May 2014 |
United States of America |
Women |
PC-1005 gel, HEC gel |
Completed |
|
OB-002H |
Microbicides |
I |
|
Poland |
MSM, Women |
|
Planned |
|
HVTN 706/ HPX3002 Mosaico |
HIV Vaccine |
III |
October 2019 |
United States of America, Argentina, Italy, Mexico, Peru, Poland, Spain |
Men |
Ad26.Mos4.HIV, gp140 |
Ongoing |
|
CONRAD A18-146 |
Microbicides, Multipurpose Prevention Technologies |
I |
December 2018 |
United States of America |
Women |
Elvitegravir (EVG), F/TAF |
Completed |
|
Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV in Brazilian transgender women (PrEParadas) |
PrEP |
Demo Project |
July 2018 |
Brazil |
|
|
Ongoing |
|
DuoGel |
Microbicides |
I |
November 2017 |
United States of America |
Women, Men |
IQP-0528 |
Ongoing |
|
MTN-041 |
Microbicides, PrEP |
Other |
May 2018 |
Malawi, South Africa, Uganda, Zimbabwe |
Women |
Dapivirine Ring, TDF/FTC (Truvada) |
Ongoing |
|
MTN-043 |
Microbicides |
Open Label |
|
Malawi, South Africa, Uganda, Zimbabwe |
Women |
Dapivirine Ring |
Planned |
|
MTN-044/IPM 053 |
Microbicides, Multipurpose Prevention Technologies |
Open Label, I |
June 2018 |
United States of America |
Women |
Dapivirine-Levonorgestrel ring |
Ongoing |
|
HVTN 125 |
HIV Vaccine |
Ib |
July 2018 |
United States of America |
|
|
Withdrawn |
|
HVTN 127/HPTN 087 |
Antibody Related Research |
I |
February 2018 |
United States of America |
Women, Men |
VRC07-523LS |
Ongoing |
|
PV1/PrEPVacc |
HIV Vaccine, PrEP |
IIb |
January 2020 |
Uganda, South Africa, United Republic of Tanzania, Mozambique |
|
DNA , MVA, Protein |
Ongoing |
|
Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women |
Microbicides |
I |
October 2017 |
United States of America |
Women |
GRFT |
Completed |
|
DREAM-01 |
Microbicides, Multipurpose Prevention Technologies |
I |
October 2016 |
United States of America, Malawi |
Men |
|
Ongoing |
|
CONRAD 137 |
PrEP |
I |
October 2016 |
|
Women |
F/TAF, TDF/FTC (Truvada) |
Completed |
